BCR and cancer: Specifically, when excluding the exams from women diagnosed with cancer within 1 year or 2 years, our MRP-BCR model obtains an AUC of 0.68 (95% CI, 0.66–0.69) and 0.68 (95% CI, 0.66–0.69) for risk prediction.